Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Institutional Ownership

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Nov 23, 2021 7:29pm

280 Views

Post# 34159483

Institutional Ownership

Renaissance Technologies picked up about 200,000 share of ONCY during second third quarter 2021.

Nice to see. Perhaps other funds will also see someting in ONC and we will finally gain some real institutional holders.

But, I do believe ONC will be bought out well before that happens. Quite soon, in fact.

They are by far ONC's largest instituional shareholder.

https://en.wikipedia.org/wiki/Renaissance_Technologies

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles